Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug645 | Brequinar Wiki | 0.71 |
| drug3728 | Standard of Care Wiki | 0.16 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
In this study, the content and results of the psychiatric consultation on patients in Corona Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state and psychological support and crisis intervention were assessed on their emotional state. Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the medical records of the request and the results of the subjects, We collected Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological scale according to differences in socio-demographic status and medical severity, and compares psychological measures before and after referral to mental health medicine to evaluate the effectiveness of psychiatric counseling.
Description: for assess depressive symptom
Measure: Change of PHQ-9 (Patient Health Questionnaire-9) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess anxiety symptom
Measure: Change of GAD-7 (Patient Health Questionnaire-9) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess PTSD symptom
Measure: Change of PC-PTSD-5 (Primary Care PTSD Screen for DSM-5) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess insomnia
Measure: Change of AIS (Athens Insomnia Scale) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess suicidal idea
Measure: Change of P4 (P4 Suicidality Screener) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess health associated QoL
Measure: Change of SF-36 (Short Form Health Survey Questionnaire) Time: On admission and at the time of discharge, on average 2 monthsDescription: for assess other psychiatric symptoms
Measure: Change of SCL-90-R Time: On admission and at the time of discharge, on average 2 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports